Titre:
  • Phase I study of lapatinib (L) and temozolomide (T) combination for the treatment of progressive brain metastases (BM) in HER2-positive metastatic breast cancer patients (Pts) (LAPTEM, LAP 111172)
Auteur:Azambuja, Evandro; Lemort, Marc; Rossari, José; Moulin, C; Buttice, A; D'Hondt, Veronique; Lebrun, Fabienne; Lalami, Yassine; Cardoso, Fatima; Sotiriou, Christos; Gil, Thierry; Devriendt, Daniel; Marinus, W.; Paesmans, Marianne; Piccart-Gebhart, Martine; Awada, Ahmad
Informations sur la publication:J Clin Oncol, ASCO Annual Meeting Proceedings, ASCO Annual meeting 2011(June 2011: Chicago, IL, USA), Vol. 29, 15 Suppl, Part I, page (62)
Statut de publication:Publié, 2011-06
Sujet CREF:Cancérologie
Médecine pathologie humaine
Langue:Anglais